Dr J Rould
Full-Time Tech Investor, Quantum/Cybersecurity, Philosophy Background
AmpliTech Group remains too risky to own despite a promising backlog. It is highly speculative with a very small market cap, falling year-over-year revenue and dilution, and like many similar speculative companies the open question is whether the backlog converts to revenue in a timely manner. The chart may finally be near support. x.comÂ
AmpliTech's downside risk is not fully priced in at current prices, even though the business has real upside. Its Massive MIMO O-RAN radio, used in Northeastern University's AI-RAN prototype with Nvidia GPUs, and its low-noise and cryogenic amplifiers give it a credible growth story, and a Telus article validates the technology. But results depend on execution and customers not delaying, dilution risk is real, and the upside is already partly priced in; a lower price would provide a floor. x.com … Show more
Rubrik belongs in the too-hard pile until it proves it can make money and stop diluting shareholders. @InvestingVisual notes that net losses, dilution and stock compensation as a share of revenue are shrinking each quarter, but trending in the right direction is not good enough for a large investment; continued proof over time could prompt a rethink. x.com x.comÂ
AmpliTech Group's revenue ramp over the rest of the year should justify its rapid run-up, even if the stock looks a bit stretched. @RKLBMan, in the post being replied to, says it now feels more fairly valued and, after rising so quickly, more like a pump and dump. x.comÂ
Ondas Holdings and Archer Aviation are dead money because endless dilution has outpaced their hot stories. Ondas shareholders haven't made a buck all year as dilution inflates its market cap, and a $460M backlog, even if fully realized, is thin against a roughly $6B market cap. Archer went the same way, climbing on a red-hot story until billions in dilution left enthusiasm unable to keep pace. The biggest cost is opportunity cost in one of the hottest markets of a lifetime. x.com x.comÂ
Richtech Robotics showed all the red flags: under $10M in the bank while trying to sell AI robots, which takes hundreds of millions to do properly, heavy at-the-market dilution, a team with little experience, and customers presented as partnerships. x.comÂ
AmpliTech's story is not broken, just pushed further out, with no fireworks expected in 2026 and 2027 potentially a very important year. It withdrew its roughly $50M revenue outlook after customers delayed deployments, but orders were not cancelled, and its new update clears up some uncertainty. It has about $17M of backlog, has shipped over $17M of ORAN products and has more than 2,000 radios deployed with a Tier-1 operator. Management targets positive EBITDA in 2027. x.comÂ
AmpliTech is priced like a parts maker at 2.6x 2026 revenue guidance despite AI-RAN and quantum growth, so a re-rating alone could drive returns. Q1 revenue rose 49% to $5.35M at a 48% gross margin with no debt; it has the only US O-RAN certified 64T64R Massive MIMO radio and supplies two Fortune 50 quantum customers. It guides $50M for 2026, and customers are skipping LOIs for purchase orders. Risks: one customer is ~50% of revenue and rights could add 36% more shares. x.comÂ
AmpliTech is booking a quantum backlog because cryogenic amplifier lead times for labs now exceed a year. Qubit readout needs amplifiers adding almost no noise at 4 kelvin, which very few shops build to spec and none can spin up in a quarter. Revenue is $24 million trailing at a 24% gross margin, with cash burn; July's $20.1 million rights offering funds the ramp but dilutes. The latest quarter fell 27% year over year; risks are lead times normalizing or Open RAN LOIs never converting. x.comÂ
AmpliTech is the overlooked supplier in the fiber buildout because its low-noise amplifiers keep signals clean over distance, the chokepoint once fiber spans millions of miles. Lumen signed $13B of fiber contracts with Microsoft, Amazon and Anthropic to reach 58M fiber miles by 2031, and that spending flows downstream. AmpliTech is qualified with defense primes and quantum labs, a hard-to-copy moat; the CEO, COO and CFO each bought 50,000 shares at $3.04 in February. Risk/reward is asymmetric. … Show more
AmpliTech's new buyback is a poor use of cash for a small growth company, typically a sign it has nothing better to spend on to spur growth; hiring talent, buying machinery or adding a warehouse would be better. Per @SpaceInvestor_D, it authorized up to $10 million of repurchases over 24 months, ended its unused ATM offering and cited record revenue, a growing order book, expected margin expansion and a debt-free, cash-strong balance sheet. The stock soared on the news. x.com x.comÂ
